Véto-pharma S.A. Company Profile

00:03 EDT 5th October 2015 | BioPortfolio

News Articles [814 Associated News Articles listed on BioPortfolio]

NMT Pharma and CAO Pharma in licensing agreement for anti-cancer drug

Biospectrum NMT Pharma and CAO Pharma will enter into agreements that would secure funding needed by CAO Pharma to cont...


Verona Pharma plc ("Verona Pharma" or the "Company") Verona Pharma appoints Dr Ken Cunningham and Dr Anders Ullman as Non-Executive Directors 8 September 2015, Cardiff - Verona Pharma plc (AIM: VR...

Endo’s Purchase of Par Pharma Shakes up the Industry

US Pharma M&A activity has yet to show any signs of a slowdown after the $8.1bn exit of Par Pharma by TPG to Endo was announced on Monday. The US Pharma industry has seen 39 deals valued at US$ 77...

Horizon Pharma plc Sends Letter to Depomed, Inc Board of Directors / Horizon Pharma Stands by Its Proposal to Acquire All the Outstanding Shares of Depomed for $33.00 a Share in Horizon Pharma Stock, Assuming Parties Can Come to a Negotiated Agreement Qu

DUBLIN, IRELAND -- (Marketwired) -- 08/13/15 -- Horizon Pharma plc (NASDAQ: HZNP) ("Horizon Pharma"), a biopharmaceutical company focused on improving patients' lives by identifying, developing, a...

Moves in pharma app market, but user longevity an issue

Pharma companies continue to invest in the mobile app market, but studies have found that pharma apps suffer the same longevity challenges as programmes in the wider market. Amsterdam-based dermatolog...

Kaldi Pharma partners A2a/A1 antagonist with CleveXel Pharma

Kaldi Pharma, a special-purpose financing vehicle concurrently created by Domain Therapeutics SA, licensed CleveXel Pharma worldwide rights to the preclinical A2a/A1 antagonist CVXL0069 (formerly DT09...

Big pharma to add $60bn in sales by 2024

Big pharma companies are set to grow their revenues by a modest 1.3% a year over the next 10 years, and oncology will slip from the top spot as the most lucrative therapy area. So says a new report on...

Eris Pharma acquires entire stake of Aurobindo Pharma unit

Aurobindo Pharma sold all of its stake in its Australian subsidiary to Eris Pharma Australia to focus on the U.S.  -More- 

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [21 Associated PubMed Articles listed on BioPortfolio]

Discovery of a novel trimebutine metabolite and its impact on N-desmethyltrimebutine quantification by LC-MS/MS.

Hélène Montpetit has a Bachelor of Science in Biochemistry from the University du Québec at Montreal. For the past 15 years, she has worked in the bioanalysis field in CROs environment as well as i...

10 years after implementation of TRIPS obligations in India.

The Patent (Amendment) Act of 2005 enforced after TRIPS raises many issues which hinder growth of Indian pharma companies. To tackle this, Indian pharma companies doubled their R&D expenditure and bec...

Starting up and spinning out: The changing nature of partnerships between pharma and academia.

Topical oxygen wound therapies for chronic wounds: a review.

Chronic wounds are an increasing problem in our ageing population and can arise in many different ways. Over the past decades it has become evident that sufficient oxygen supply is an essential factor...

Initial Clinical Results of a New Telescopic IOL Implanted in Patients With Dry Age-Related Macular Degeneration.

To evaluate the safety and efficacy of the iol-AMD technology (London Eye Hospital Pharma, London, UK), which includes two injectable, hydrophobic acrylic intraocular lenses (IOLs) in a pilot study of...

Clinical Trials [53 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [670 Associated Companies listed on BioPortfolio]

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

FranceMed Pharma

FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. Fr...

Flex Pharma, Inc.

Flex Pharma, Inc. is a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders. Flex Pharma has demonstrated initial human effi...

More Information about "Véto-pharma S.A." on BioPortfolio

We have published hundreds of Véto-pharma S.A. news stories on BioPortfolio along with dozens of Véto-pharma S.A. Clinical Trials and PubMed Articles about Véto-pharma S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Véto-pharma S.A. Companies in our database. You can also find out about relevant Véto-pharma S.A. Drugs and Medications on this site too.


Corporate Database Quicklinks

Searches Linking to this Company Record